Kaushal Parikh

Kaushal Parikh is a researcher at Erasmus MC, specifically within the Department of Gastroenterology & Hepatology. His work spans clinical and molecular aspects of gastrointestinal diseases, with a strong focus on inflammatory bowel disease, enteric nervous system biology, and translational clinical trials.

His research interests include:

• Inflammatory Bowel Disease (Crohn’s disease and ulcerative colitis)
• Enteric glia and neurogastroenterology
• Kinome and kinase signaling pathways in gut health and disease
• Genotyping and genetic divergence in gastrointestinal disorders
• Mucosal immunology and immune response modulation
• Randomized controlled trials in gastroenterological interventions

The recent publications highlight a trend toward integrating molecular mechanisms with clinical outcomes, especially in predicting disease recurrence and treatment response. His work often involves collaboration with multidisciplinary teams across Europe, particularly in large-scale trials such as the CoBaGI study. Topics frequently explored include mucosal healing, stent efficacy, and cellular heterogeneity in the gut.

Scientific contributions include:

• Original research in high-impact journals like Gastroenterology and The Lancet Gastroenterology and Hepatology
• Systematic reviews synthesizing evidence on postoperative Crohn’s recurrence
• Commentaries on emerging concepts in intestinal motility and signaling

Dr. Parikh has been involved in advising and collaborative research, particularly in projects related to Hirschsprung disease and IBD management, though no formal students are listed. He participates in major research consortia, such as the Dutch Mesenteric Ischemia Study Group, indicating active engagement in national and international networks. While specific grants are not mentioned, his involvement in multicenter trials suggests funded research activity. His work contributes to both mechanistic understanding and clinical innovation in gastroenterology.

He is associated with advanced research environments focusing on:

• Molecular profiling of gastrointestinal tissues
• Translational models of gut innervation and inflammation
• Clinical trial design and execution in digestive diseases